ABBOTT LABS: Sept. 12 Deadline Set for HUMIRA Ruling Review

Subscribe
TOPICS: Drugs/Pharmaceuticals | Health Care | Legal Issues, Litigation | Patents, Intellectual Prop. | SEC-Qtrly, Annual Reports | Securities & Exch Comm, US
LOCATIONS: Texas | United States